跳至主要内容
临床试验/NCT05633004
NCT05633004已完成不适用

Assessment of the Vivio System for the Non-Invasive Estimation of Left Ventricular Diastolic Pressure (LVDP) as an Aid in the Diagnosis of Heart Failure

Avicena LLC2 个研究点 分布在 1 个国家目标入组 406 人开始时间: 2021年9月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Avicena LLC
入组人数
406
试验地点
2
主要终点
The primary endpoints are the sensitivity and specificity of the Vivio Cuff System for predicting elevated versus non elevated LVEDP as compared to direct measurement of LVEDP in the combined Cath Lab and Healthy Cohorts

研究概览

简要总结

The purpose of the study is to determine the relationship between non-invasive measurement of left ventricular diastolic pressure (LVDP) using the Vivio System, compared with invasively measured LVDP via direct measurement during left heart catheterization.

详细描述

Prospective study to document the utility of Vivio in quantifying LVDP, using directly measured LVDP collected during left heart catheterization as the comparator.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult subjects >21 years of age.
  • Referred for non-emergent left heart catheterization inclusive of direct measurement of LVDP as part of routine clinical management, to be performed from a femoral or radial access site.
  • Willing and able to participate in all study evaluations and allow access to medical records, including medical testing records.
  • Ability to understand and sign informed consent or have a legally authorized representative to provide informed consent on behalf of the subject.

排除标准

  • Acute coronary syndrome, or documented MI within a week of scheduled catheterization, cardiogenic shock, or the need for intravenous inotropic or mechanical circulatory support.
  • Carotid pulse is not palpable by a trained study researcher.
  • History of carotid sinus hypersensitivity (fainting in response to minimal touching or positioning of the neck).
  • History of significant or symptomatic carotid artery disease, including TIA, ultrasound evidence of >60% carotid stenosis, or at the discretion of the investigator; history of carotid artery stenting or surgery.
  • Open skin lesions at the site of Vivio application / examination.
  • Contraindication to placing a catheter in the LV in the judgement of the investigator (e.g., mechanical aortic valve, left ventricular thrombus, etc.).
  • Inability to obtain brachial artery blood pressure.

结局指标

主要结局

The primary endpoints are the sensitivity and specificity of the Vivio Cuff System for predicting elevated versus non elevated LVEDP as compared to direct measurement of LVEDP in the combined Cath Lab and Healthy Cohorts

时间窗: 1 year

The primary endpoints are the sensitivity and specificity of the Vivio Cuff System for predicting elevated versus non elevated LVEDP as compared to direct measurement of LVEDP in the combined Cath Lab and Healthy Cohorts

次要结局

未报告次要终点

研究者

发起方
Avicena LLC
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Avicena LVDP Validation Study | 临床试验